The Affiliated Hospital Of Xuzhou Medical University

This early study tests a new drug called HN2302 in 6 adults with refractory myasthenia gravis, a condition causing severe muscle weakness. The main goal is to see if the drug is safe and tolerable. Researchers will also check if it helps with daily activities like walking or eati…

This early-phase study tests a new drug (AT1019) given with targeted radiation and an immunotherapy drug in people with advanced solid tumors that have not responded well to prior treatment. The main goal is to find the safest dose and check for side effects. About 12 adults will…

This study tests a combination of five drugs (tislelizumab, cyclophosphamide, mitoxantrone liposomes, chidamide, and prednisone) in 40 adults newly diagnosed with angioimmunoblastic T-cell lymphoma (AITL), a rare and aggressive blood cancer. The goal is to see if this mix improve…

This study looks at how certain genes might influence how well type 2 diabetes medications like exenatide work. Researchers will review medical records from 300 adults with type 2 diabetes who have taken these drugs for at least 6 months. The goal is to find patterns that could h…